An Investigation of TAS-119 Monotherapy

A Safety, Tolerability and Pharmacokinetic Study of TAS-114 in Combination With Capecitabine in Patients With Advanced Solid Tumors

NCT02025803 ·Status: COMPLETED ·Phase: PHASE1

SMP-3124LP in Adults With Advanced Solid Tumors

NCT06526819 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Open-Label Study to Assess the Safety/Tolerability in Patients With Solid Tumors

NCT00820560 ·Status: COMPLETED ·Phase: PHASE1

Dose Escalation Study of TAK-117 (MLN1117) in Subjects With Advanced Cancer

NCT01449370 ·Status: COMPLETED ·Phase: PHASE1

Subjects With Advanced or Metastatic Solid Tumor Malignancies

NCT05474859 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Study of the of the Safety and Tolerability of TT-00434 in Patients With Advanced Solid Tumors

NCT04830501 ·Status: COMPLETED ·Phase: PHASE1

Study of ASTX029 in Subjects With Advanced Solid Tumors

NCT03520075 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety and Pharmacokinetics of SAR245408 Daily Oral in Patients With Solid Tumors

NCT01392924 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Cardiac Safety of TAS-102 in Patients With Advanced Solid Tumors

NCT01867879 ·Status: COMPLETED ·Phase: PHASE1

Evaluating the Safety and Tolerability of GDC-0349 in Patients With Locally Advanced or Metastatic Solid Tumors or Non Hodgkin's Lymphoma

NCT01356173 ·Status: COMPLETED ·Phase: PHASE1

Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors.

NCT03891953 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Phase I Study of TAS-106 in Combo With Carboplatin

NCT00752011 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor

NCT04192344 ·Status: RECRUITING ·Phase: PHASE1

Safety Study of TAK-593 Given Orally in Subjects With Nonhematologic Advanced Cancer

NCT00773929 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors

NCT04242199 ·Status: COMPLETED ·Phase: PHASE1

A Safety and Pharmacokinetic Study of TAK-228 in Combination With TAK-117 in Adult Participants With Advanced Nonhematologic Malignancies

NCT01899053 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Tolerance, Efficacy and Pharmacokinetics of TQB3558 Tablets

NCT04408079 ·Status: UNKNOWN ·Phase: PHASE1

Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas

NCT02503423 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

A Phase 1 Study of ADA-011 for Subjects With Advanced Solid Tumors

NCT05601219 ·Status: TERMINATED ·Phase: PHASE1

Study of XL820 in Adults With Solid Tumors

NCT00129571 ·Status: COMPLETED ·Phase: PHASE1

Study of AK119 in Subjects With Advanced Solid Tumors

NCT05173792 ·Status: COMPLETED ·Phase: PHASE1

Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors

NCT04742959 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Evaluate the Safety, Tolerability of DN1508052-01 in Advanced Solid Tumors

NCT03934359 ·Status: COMPLETED ·Phase: PHASE1

Safety and Preliminary Efficacy of BNA035 in Patients With Advanced Solid Tumors

NCT05150457 ·Status: RECRUITING ·Phase: PHASE1

A Phase 1, Open-Label, Randomized, Cross-Over, Pharmacokinetic Study Evaluating the Effect of S-1 on Advanced Solid Tumors

NCT00400023 ·Status: COMPLETED ·Phase: PHASE1